Spyre Therapeutics SYRE
NASDAQ SYRE
$89.03 +4.31 (+5.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Total Liabilities (2015 - 2026)

Updated

Spyre Therapeutics (SYRE) reported Total Liabilities of $71.86 million for Q2 2026, down 13.5% from $83.06 million a year earlier and down 22.8% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Total Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Spyre Therapeutics posted Total Liabilities of $62.55 million, down 31.0% from FY2024.

  • Total Liabilities has a five-year compound annual growth rate of 23.5% (FY2020 to FY2025).
  • By year, Total Liabilities came in at $90.68 million in FY2024 (-42.6%), $157.84 million in FY2023 (+657.4%), $20.84 million in FY2022 (-19.8%) and $25.99 million in FY2021 (+19.3%).
  • Five-year quarterly Total Liabilities spans a low of $18.8 million in Q1 2023 and a high of $452.67 million in Q3 2023.
  • Year over year, Total Liabilities gained in two of the last eight quarters, with an average decline of 30.8%.
  • The high point for year-over-year Total Liabilities in five years was Q4 2023 (growth of 657.4%); the low point was Q2 2024 (a decline of 86.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $93.14 million (Q1 2026), $62.55 million (Q4 2025) and $49.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 116.09 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 141.05 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 65.46 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 7.18 Bn
10 Spyre Therapeutics 7.46 Bn 7.46 Bn - 71.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71.86 Mn
Mar 31, 2026 93.14 Mn
Dec 31, 2025 62.55 Mn
Sep 30, 2025 49.50 Mn
Jun 30, 2025 83.06 Mn
Mar 31, 2025 87.17 Mn
Dec 31, 2024 90.68 Mn
Sep 30, 2024 93.70 Mn
Jun 30, 2024 61.68 Mn
Mar 31, 2024 335.33 Mn
Dec 31, 2023 157.84 Mn
Sep 30, 2023 452.67 Mn
Jun 30, 2023 450.90 Mn
Mar 31, 2023 18.80 Mn
Dec 31, 2022 20.84 Mn
Sep 30, 2022 24.01 Mn
Jun 30, 2022 22.55 Mn
Mar 31, 2022 21.51 Mn
Dec 31, 2021 25.99 Mn
Sep 30, 2021 26.98 Mn
API Access

Spyre Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=SYRE&period=max&api_key=YOUR_API_KEY